Topics
Healthcare, biotech, medtech and pharmaceutical research connected to product cycles and clinical innovation.
The market assumes a steady, extended US inventory restocking cycle through the second half of the year, but actual trade data reveals a compressed cycle…
The market treats Sodexo as a uniformly weak top-line story, but the data reveals a sharp structural divergence between accelerating Rest of World growth and…
The market treats AI in biopharma as a distant speculative trend, but data reveals it is already a measurable productivity engine accelerating drug discovery…
The market treats Novartis (NOVN.S) as a stable growth story with a supportive pipeline, but the reality is that its current valuation already prices in full…
The market treats Cochlear's growth as decelerating toward low single digits, but actual implant volumes grew 8.8% YoY in FY24A, and the upcoming UK NHS…
The market treats Ajinomoto's US Healthcare division as a low-margin CDMO, but Forge's customer quality upgrade is driving revenue acceleration and a clear…
The market treats all Brazilian education stocks as uniformly exposed to the SELIC curve, but cash flow generation is the true differentiator. Yduqs' robust…
The market treats Fresenius Medical Care as a broad-based recovery story, but the data reveals EBIT growth is driven by cost cuts rather than revenue…
Resmed (RMD.AX) Income Statement Growth Rates (pcp) CAGR June Year End (US$m) FY22A FY23A FY24A FY25A FY26E FY27E FY28E FY22A FY23A FY24A FY25A FY26E FY27E…
Chris Schott, CFA AC North America Equity Research (1-212) 622-5676 19 June 2026 JPMORGAN [email protected] the company pages of our client…
the company pages of our client website, http://www.jpmorganmarkets.com . This report also sets out within it the material underlying Chris Schott, CFA AC…
and Healthcare Services (Lisa Gill), Managed Medicaid (John Stansel, CFA), Lisa C. Gill AC Hospitals and Facilities (Ben Rossi). Below, please find our…
Overview:Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the…
Citi's flash note on JCR Pharmaceuticals (4552.T) highlights the company's J-Brain Cargo (JBC) drug delivery platform and pipeline including JR-171, JR-141…
UBS reiterates its year-end Stoxx 600 target of 630 as the MOU to reopen the Strait of Hormuz pushes the index above that level, but warns Europe is entering…
UBS’s daily US healthcare sector note highlights Animal Health crowding trends showing ZTS crowded long while ELAN and IDXX are crowded short. Vet visits…
UBS highlights that Bristol-Myers Squibb management may provide an updated timing for the milvexian Phase III AFib trial (LIBREXIA-AF) as early as the Q2…
TCM raw material prices continued their downward trend, with the TCM Raw Materials Price Composite 200 Index falling 15% YoY in the first five months of 2026…